Literature DB >> 10764514

Update on the Role of Immunotherapy in the Management of Kidney Cancer.

.   

Abstract

Entities:  

Year:  1996        PMID： 10764514     DOI： 10.1177/107327489600300617

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  5 in total

1.  Dynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors.

Authors:  Gilda Gali Hillman; Vinita Singh-Gupta; Areen K Al-Bashir; Hao Zhang; Christopher K Yunker; Amit D Patel; Seema Sethi; Judith Abrams; E Mark Haacke
Journal:  Transl Oncol       Date:  2010-10-01       Impact factor: 4.243

2.  Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.

Authors:  Gilda G Hillman; Vinita Singh-Gupta; Hao Zhang; Areen K Al-Bashir; Yashwanth Katkuri; Meng Li; Christopher K Yunker; Amit D Patel; Judith Abrams; E Mark Haacke
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

3.  Interferon-gamma-induced nitric oxide inhibits the proliferation of murine renal cell carcinoma cells.

Authors:  David J Tate; John R Patterson; Cruz Velasco-Gonzalez; Emily N Carroll; Janie Trinh; Daniel Edwards; Ashok Aiyar; Beatriz Finkel-Jimenez; Arnold H Zea
Journal:  Int J Biol Sci       Date:  2012-09-06       Impact factor: 6.580

4.  Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.

Authors:  Gilda G Hillman; Yu Wang; Mingxin Che; Julian J Raffoul; Mark Yudelev; Omer Kucuk; Fazlul H Sarkar
Journal:  BMC Cancer       Date:  2007-01-09       Impact factor: 4.430

Review 5.  Heading Towards a Possible Rebirth of the Induced Renal Cell Carcinoma Models?

Authors:  Clarisse R Mazzola; Domenico Ribatti
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.